Stay updated on CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Upgraded to version v3.2.0 with a funding-status notice about operational limitations; v3.1.0 was removed. Indicates a maintenance/availability update rather than new content.
    Difference
    13%
    Check dated 2025-10-04T02:59:04.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Update versioning from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.3%
    Check dated 2025-09-27T02:10:41.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Only the revision label was updated, from v3.0.1 to v3.0.2; the rest of the page content appears unchanged.
    Difference
    0.3%
    Check dated 2025-09-12T17:17:18.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.3%
    Check dated 2025-09-05T13:54:14.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the addition of a facility name and location, while several location-related details have been removed.
    Difference
    4%
    Check dated 2025-08-29T08:33:32.000Z thumbnail image
  8. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.3%
    Check dated 2025-08-15T00:11:46.000Z thumbnail image

Stay in the know with updates to CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CT103A in Relapsed/Refractory Multiple Myeloma Clinical Trial page.